Branched cationic copolymers and methods for antimicrobial use

Details Branched cationic copolymers and methods for antimicrobial use Branched cationic copolymers and methods for antimicrobial use

2003-11-25

2008-12-16

Tate, Christopher R. (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S329000

Reexamination Certificate

active

07465708

ABSTRACT:
The invention provides a branched copolymer for the treatment of bacterial, fungal, and viral infections. The branched copolymer is characterized as having (i) at least 10 amino acids, (ii) at least 10% of the amino acids are histidine, (iii) at least 10% of the amino acids are non-histidine, (iv) said branched polymer comprising one or more backbones, (v) one or more terminal branches, and (vi) optionally, one or more non-terminal branches.

REFERENCES:
patent: 4847240 (1989-07-01), Ryser et al.
patent: 5354844 (1994-10-01), Beug et al.
patent: 5554388 (1996-09-01), Illum et al.
patent: 5670347 (1997-09-01), Gopal
patent: 5736392 (1998-04-01), Hawley-Nelson et al.
patent: 5856435 (1999-01-01), Bazile et al.
patent: 5912230 (1999-06-01), Oppenheim et al.
patent: 5985354 (1999-11-01), Mathiowitz et al.
patent: 6051429 (2000-04-01), Hawley-Nelson et al.
patent: 6113946 (2000-09-01), Szoka, Jr. et al.
patent: 6312727 (2001-11-01), Schacht et al.
patent: 6372499 (2002-04-01), Midoux et al.
patent: 6475004 (2002-11-01), Shuey et al.
patent: 6692911 (2004-02-01), Pack et al.
patent: 7070807 (2006-07-01), Mixson
patent: 7163695 (2007-01-01), Mixson
patent: 2001/0006817 (2001-07-01), Pack et al.
patent: 0 727 223 (1996-08-01), None
patent: WO-98/22610 (1998-05-01), None
patent: WO-99/42091 (1999-08-01), None
patent: WO-00/32764 (2000-06-01), None
patent: WO-01/47496 (2001-07-01), None
Midoux et al., Membrane Permeabilization and Efficient Gene Transfer by a Peptide Containing Several Histidines.Bioconjugate Chem98, 9, 260-267.
Midoux et al., Efficient Gene Transfer by Histidylated Polylysine/pDNA Complexes.Bioconjugate ChemMay-Jun. 1999; 10(3):406-411.
Chen et al., Co-polymer of histidine and lysine markedly enhances transfection efficiency of liposomes.Gene TherOct. 2000; 7(19):1698-1705.
Chen et al., Branched co-polymers of histidine and lysine are efficient carriers of plasmids.Nucleic Acids ResMar. 15, 2001; 29(6):1334-1340.
Pichon et al., Histidylated oligolysines increase the transmembrane passage and the biological activity of antisense oligonucleotides.Nucleic Acids ResJan. 15, 2000; 28(2):504-512.
Putnam, D. et al., Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini.PNAS98(3), Jan. 30, 2001, pp. 1200-1205.
Bechinger, B., Kinder, R., Helmle, M., Voogt, T.C., Harzer, U. and Schinzel, S. (1999). Peptide structural analysis by solid-state NMR spectroscopy.Biopolymers51, 174-90.
Bellm, L., Lehrer, R. J. and Ganz, T. (2000). Protegrins: new antibiotics ofmammalian origin.Expert Opin Investig Drugs9, 1731-42.
Blanc, E., Fremont, V., Sizun, P., Meunier, S., Van Rietschoten, J., Thevand, A., Bemassau, J.M. and Darbon, H. (1996). Solution structure of PO1, a natural scorpion peptide structurally analogous to scorpion toxins specific for apamin- sensitive potassium channel.Proteins24, 359-69.
Bontems, F., Roumestand, C., Gilquin, B., Menez, A. and Toma, F. (1991). Refined structure of charybdotoxin: common motifs in scorpion toxins and insect defensins.Science254, 1521-3.
Chen, Q.R., Zhang, L., Stass, S.A. and Mixson, A.J. (2001). Branched co-polymers of histidine and lysine are efficient carriers of plasmids.Nucleic Acids Res.29, 1334-1340.
Cruz, L.J., Johnson, D.S. and Olivera, B.M. (1987). Characterization of the omega-conotoxin target. Evidence for tissue-specific heterogeneity in calcium channel types.Biochemistry26, 820-4.
Dathe, M. and Wieprecht, T. (1999). Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells.Biochim Biophys Acta1462, 71-87.
Epand, R.M. and Vogel, H.J. (1999). Diversity of antimicrobial peptides and their mechanisms of action.Biochim Biophys Acta1462, 11-28.
Giacometti, A., Cirioni, O., Ghiselli, R., Viticchi, C., Mocchegiani, F., Riva, A., Seba, V. and Scalise, G. (2001). Effect of mono-dose intraperitoneal cecropins in experimental septic shock.Crit Care Med29, 1666-9.
Gilles, M., Krimm, J., Bouet, F., Froy, O., Gurevitz, M., Lancelin, J.M. and Gordon, D. (2000). Structural implications on the interaction of scorpion alpha-like toxins with the sodium channel receptor site inferred from toxin iodination and pH-dependent binding.J Neurochem75, 1735-45.
Hancock, R.E. (1997). Peptide antibiotics.Lancet349, 418-22.
Hancock, R.E. (1999). Host defense (cationic) peptides: what is their future clinical potential?Drugs57, 469-73.
Hancock, R.E. and Lehrer, R. (1998). Cationic peptides: a new source of antibiotics.Trends Biotechno16, 82-8.
Harder, J., Bartels, J., Christophers, E. and Schroder, J.M. (2001). Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic.J Biol Chem276, 5707-13.
Hoover, D.M., Chertov, O. and Lubkokwski, J. (2001). The structure of human beta-defensin-1: new insights into structural properties of beta-defensins.J Biol Chem276, 39021-6.
Hughes, A.L. (1999). Evolutionary diversification of the mammalian defensins.Cell Mol Life Sci56, 94-103.
Jia, H.P., Mllls, J.N., Barahmand-Pour, F., Nishimura, D., Mallampali, R.K., Wang G., Wiles, K., Tack, B.F., Bevins, C.L. and McCray, P.B., Jr. (1999). Molecular cloning and characterization of rat genes encoding homologues of human beta-defensins.Infect Immun67, 4827-33.
Kourie, J.I. and Shorthouse, A.A. (2000). Properties of cytotoxic peptide-formed ion channels.Am J Physiol Cell Physiol278, C1063-87.
La Rocca, P., Biggin, P.C., Tieleman, D.P. and Sansom, M.S. (1999). Simulation studies of the interaction of antimicrobial peptides and lipid bilayers.Biochim Biophys Acta1462, 185-200.
Lehrer, R.I. and Ganz, T. (1996). Endogenous vertebrate antibiotics. Defensins, protegrins, and other cysteine-rich antimicrobial peptides.Ann NY Acad Sci797, 228-39.
Mallow, E.B., Harris, A., Salzman, N., Russell, J.P., DeBerardinis, R.J., Ruchelli, E. and Bevins, C.L. (1996). Human enteric defensins. Gene structure and developmental expression.J Biol Chem271, 4038-45.
Martin, M.F. and Rochat, H. (1984). Purification of thirteen toxins active on mice from the venom of the North African scorpionButhus occitanus tunetanus. Toxicon22, 279-91.
Mosca, D.A., Hurst, M.A., So, W., Viajar, B.S., Fujii, C.A. and Falla, T.J. (2000). IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis.Antimicrob Agents Chemother44, 1803-8.
Oppenheim, F.G., Xu, T., McMillian, F.M., Levitz, S.M., Diamond, R.D., Offner, G.D. and Troxler, R.F. (1988b). Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects onCandida albicans. J Biol Chem263, 7472-7.
Oppenheim, F.G., Xu, T., McMillian, F.M., Levitz, S.M., Diamond, R.D., Offner, G.D. and Troxler, R.F. (1988a). Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects onCandida albicans. J Biol Chem263, 7472-7.
Oren, Z., Lerman, J.C., Gudmundsson, G.H., Agerberth, B. and Shai, Y. (1999). Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity.Biochem J341, 501-13.
Oren, Z. and Shai, Y. (1998). Mode of action of linear amphipathic alpha-helical antimicrobial peptides.Biopolymers47, 451-63.
Oren, Z., Ramesh, J., Avrahami, D., Suryaprakash, N., Shai, Y. and Jelinek, R. (2002), Structures and mode of membrane interaction of a short alpha helical lytic peptide and its diastereomer determined by NMR, FTIR, and fluorescence spectroscopy,Eur J Biochem269, 3869-80.
Otvos, L, Jr. (2000). Antibacterial peptides isolated from insects.J Pept Sci6, 497-511.
Otvos, L., Jr., Bokonyi, K., Varga, L, Otvos, B.I., Hoffmann, R., Ertl, H.C., Wade, J.D., McManus, A.M., Craik, D.J. and Bulet, P. (2000). Insect peptides with improved protease-resistance protect mice against bacterial infection.Protein Sci9, 742-9.
Peschel, A. and Collins, L.V. (2001). Staphylococcal resistance to antimicrobial peptides of mammalian and

Affiliated with

Also associated with

Rating

Branched cationic copolymers and methods for antimicrobial use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Branched cationic copolymers and methods for antimicrobial use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Branched cationic copolymers and methods for antimicrobial use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4027241